TRAMAL RETARD 200 MG TBL PRO 10 III

What is the maximum co-payment for TRAMAL RETARD?

If the insurance company contributes, the maximum co-payment is 23,80 Kč. The maximum pharmacy price is 91,79 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does TRAMAL RETARD have a counted co-payment set?

Yes, the medicine has a counted co-payment of 25,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

67,99 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe TRAMAL RETARD?

Prescription is not conditional on a medical specialization.

What is the composition of TRAMAL RETARD?

Tramadol-hydrochlorid (200 mg), neznámá látka s kódem 14508, koloidní bezvodý oxid křemičitý, magnesium-stearát, neznámá látka s kódem 3755, neznámá látka s kódem 10258, monohydrát laktosy, makrogol 6000, propylenglykol, ointmentek, neznámá látka s kódem 4479, červený oxid železitý, oxid titaničitý, neznámá látka s kódem 4954. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to TRAMAL RETARD?

The medicine belongs to ATC group N02AX02 – TRAMADOL. Medicines with the same active substance can be found here.

Who manufactures TRAMAL RETARD?

STADA Arzneimittel AG, Bad Vilbel (D)

Is the medicine in shortage?

The latest report from the manufacturer is from 24. 5. 2024. Production was terminated with effect from 1. 8. 2024. The manufacturer lists medicines with the following code as a potential substitute: